References
- DeVita V T, Jr, Canellos G P, Chabner B, et al. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1975; 1: 248–250
- Schein P S, DeVita V T, Jr, Hubbard S, et al. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisolone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. Ann Intern Med 1976; 85: 417–422
- Fisher R I, DeVita V T, Jr, Johnson B L, et al. Prognostic factors in advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med 1977; 63: 177–182
- Gayner E R, Ultmann J E, Golomb H M, et al. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, Oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution. J Clin Oncol 1985; 3: 1596–1604
- Coltman C A, Dahlberg S, Jones S E, . Southwest Oncology Group studies in diffuse large cell lymphoma: a subset analysis. Cancer Chemotherapy: Challenges for the Future, K Kimura, et al. Excerpta Medica, Tokyo 1988; 194–202
- Fisher R I, Gaynor E R, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimes for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002–1006
- Shipp M A. Prognostic factors in aggressive non-Hodgkin's lymphoma: who has “high-risk” disease?. Blood 1994; 83: 1165
- Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B cell lymphoma. N Engl J Med 2002; 346: 235–242
- Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Fermé C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 2005; 23: 4117–4126
- Sehn L H, Berry B, Chhanabhai M, et al. Revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 2007; 109: 1857–1861
- Jaffe E. Tumours of Hematopoietic and Lymphoid Tissues. IARC Press, Lyon 2001, World Health Organization Classification of Tumours
- Altman G D. Practical Statistics for Medical Research. Chapman and Hall, London 1991
- Coiffier B. State-of-the-art therapeutics: diffuse large B-cell lymphoma. J Clin Oncol 2005; 23: 6387–6393